Fidelcrest has launched a compelling January Offer for traders. Effective from January 15, 2024, at 18:00 EET, until January 17, 2024, at 23:59 EET, this limited-time promotion brings substantial benefits for those exploring Fidelcrest’s Challenge Accounts.
Traders can avail themselves of a remarkable 25% discount on any Fidelcrest Challenge Account, irrespective of size or type. This reduction in fees aims to provide traders with a financial advantage as they navigate the complexities of the forex markets.
Fidelcrest January Offer
Moreover, Fidelcrest is offering a 125% refund to traders acquiring Challenge Accounts during this promotional period. This unique refund policy is going to empower traders further and offer an extra incentive to embark on their trading journey with Fidelcrest.
To participate in this exclusive promotion, interested traders need to sign up on Fidelcrest’s platform and use the PROMO CODE: JANUARY25 during the account acquisition process. This ensures eligibility for both the 25% discount and the remarkable 125% refund.
Fidelcrest’s January Offer underscores the firm’s commitment to supporting and rewarding traders globally. As the prop landscape evolves, Fidelcrest continues to provide tools and opportunities that empower traders to excel in their endeavors.
Traders have to act promptly, as the January Offer concludes on January 17, 2024, at 23:59 EET. Seize this unique opportunity to enhance your trading experience with Fidelcrest by visiting their official website and signing up today.
About the Firm
Fidelcrest is a proprietary trading firm that allows traders to access larger capital and make a difference in their lives. They are a globally operating company with headquarters in Nicosia, Cyprus. Their goal is to help retail traders worldwide make consistent and steady gains over longer periods of time. Traders have the opportunity to earn substantial profits, with the flexibility to manage account sizes up to $1,000,000 and receive up to 90% profit splits.
Also, don’t forget to read the Review.